|
|
Effect observation and nursing of Somatostatin in the treatment of patients with esophageal-gastric varices bleeding |
GAO Yan |
The First of Department of Gastroenterology,Shenyang Sixth People′s Hospital,Liaoning Province,Shenyang 110001,China |
|
|
Abstract Objective To investigate the effect of Somatostatin in the treatment of patients with esophageal-gastric varices bleeding (EGVB) and nursing care.Methods A total of 80 EGVB patients admitted to Shenyang Sixth People′s Hospital from April to July 2020 were selected and divided into the control group (n=40) and the treatment group (n=40) according to the random number table method.The control group was treated with conventional Terley Vasopressin,while the treatment group treate with Somatostatin on the basis of the control group.The two groups were treated with comprehensive nursing intervention and treatment until discharge from hospital,and the treatment cycle was 3 d.The hemostasis time,blood transfusion volume in the process of treatment and rebleeding rate after treatment were compared between two groups;the changes of central venous pressure (CVP),portal static pressure (PVP) and motilin(MTL),gastrin (GAS),glucagon (GLC) in the serum in T0-T4 period were compared between the two groups.Results The hemostasis time of the treatment group was shorter than that of the control group,the difference was statistically significant (P<0.05).There was no significant difference in blood transfusion volume between the two groups (P>0.05),there was no significant difference in rebleeding rate between the two groups after treatment (P>0.05).Compared with before treatment,there was no significant change of CVP in the two groups after treatment (P>0.05).The levels of PVP,MTL,GAS and GLC in the serum of the two groups all decreased after treatment,and the indexes in the treatment group were lower than those of the control group,the differences were statistically significant (P<0.05).Conclusion Somatostatin can significantly improve the hemodynamic indexes and gastrointestinal hormone GAS,MTL,GLC in the serum in EGVB patients,and enhance the therapeutic effect.
|
|
|
|
|
[1] |
李辉龙.食管胃静脉曲张出血在院前急救中的处置进展[J].临床医药文献电子杂志,2018,5(12):194-196.
|
[2] |
肖勇,于红刚,陈明锴.肝硬化门静脉高压食管胃静脉曲张出血的内镜诊治策略[J].中华消化内镜杂志,2018,11(2):84-88.
|
[3] |
陈伟,陈彬,刘丽雅.生长抑素联合特利加压素治疗食管胃底静脉曲张破裂出血的疗效评价[J].中外医疗,2019,8(2):116-118.
|
[4] |
薛长军.国产生长抑素治疗肝硬化食管胃底静脉曲张破裂出血的疗效分析[J].北方药学,2019,16(6):131.
|
[5] |
黄冬梅.肝硬化伴食管胃底静脉曲张破裂大出血的临床护理研究进展[J].临床医药文献电子杂志,2017,2(9):1774.
|
[6] |
池肇春.实用临床肝病学[M].北京:人民军医出版社,2015:758.
|
[7] |
米日古丽·吾甫尔,张志强,姚萍,等.肝硬化食管胃底静脉曲张破裂出血患者预后因素分析[J].中国中西医结合消化杂志,2018,26(1):73-77.
|
[8] |
赵丽芳,路伟,薛晶,等.生长抑素联合三腔二囊管治疗肝硬化并食管胃底静脉曲张破裂出血的疗效分析[J].河北医学,2017,23(11):1836-1839.
|
[9] |
柯达,吴振华.内镜下硬化剂注射治疗食管胃底静脉曲张破裂出血的临床疗效[J].中国病案,2018,19(5):100-102.
|
[10] |
王桂良,邱萍,徐林芳.内镜下食管静脉曲张套扎术分别联用生长抑素或特利加压素或奥曲肽治疗食管胃底静脉曲张破裂出血住院成本-效果分析[J].中国全科医学,2018,21(15):1877-1881.
|
[11] |
叶营,孙相钊,蔡春调,等.内镜联合药物诊治肝硬化食管胃底静脉曲张破裂出血的疗效及再出血危险因素研究[J].海南医学,2017,28(3):374-378.
|
[12] |
陆娴,周雪珍,王静,等.综合护理在内镜下治疗食管胃底静脉曲张出血中的效果探讨[J].中国实用护理杂志,2020,36(6):415-418.
|
[13] |
蔡红秀.肝硬化并食管胃底静脉曲张破裂出血的诱因及护理分析[J].实用临床护理学电子杂志,2017,2(44):19.
|
[14] |
任卫华,武雨侠.内镜套扎术联合生长抑素治疗肝硬化并发食管静脉曲张出血的效果分析[J].医药前沿,2019,9(27):120-121.
|
[15] |
龚敏,王桂良,林秋满,等.早期生长抑素和/或特利加压素联合内镜处理治疗肝硬化食管胃底静脉曲张破裂出血效果研究[J].中国全科医学,2019,22(36):4439-4446.
|
|
|
|